ALL KEYWORDS
Atypical Teratoid Rhabdoid Tumor
Related Specialists
Showing 3 of 21
Related Fact Sheets
Related Clinical Trials
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
- Brain & Other Nervous System Cancers
PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and Expansion Study of AZD3470, a MTA Cooperative PRMT5 Inhibitor, as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumours That Are MTAP Deficient
- Phase 1 Cancers
Related Departments
Showing 3 of 8